Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
E. Vegt, A. Eek, W. Oyen, M. de Jong, M. Gotthardt and O. BoermanArticles
EJNMMI
2010
226--234
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention
E. Vegt, M. de Jong, J. Wetzels, R. Masereeuw, M. Melis, W. Oyen, M. Gotthardt and O. BoermanArticles
JNM
2010
1049--1058
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib
I. Desar, A. Stillebroer, E. Oosterwijk, W. Leenders, C. van Herpen, W. van der Graaf, O. Boerman, P. Mulders and W. OyenArticles
JNM
2010
1707--1715
Molecular imaging of angiogenesis with SPECT
I. Dijkgraaf and O. BoermanArticles
EJNMMI
2010
S104--S113
SUV: from silly useless value to smart uptake value
E. Visser, O. Boerman and W. OyenArticles
JNM
2010
173--175
The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours
B. Dijkman, O. Schuurbiers, D. Vriens, M. Looijen-Salamon, J. Bussink, J. Timmer-Bonte, M. Snoeren, W. Oyen, H. van der Heijden and L. de Geus-OeiArticles
EJNMMI
2010
2037--2047
Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner
J. Disselhorst, M. Brom, P. Laverman, C. Slump, O. Boerman, W. Oyen, M. Gotthardt and E. VisserArticles
JNM
2010
610--617
A novel facile method of labeling octreotide with (18)F-fluorine
P. Laverman, W. McBride, R. Sharkey, A. Eek, L. Joosten, W. Oyen, D. Goldenberg and O. BoermanArticles
JNM
2010
454--461
Bone-marrow uptake of (18)F-FDG during fever
F. Vos, C. Bleeker-Rovers, C. Delsing, B. Kullberg and W. OyenArticles
LANCETID
2010
509--10; author reply 510-1
Calcium sensitivity and the Frank-Starling mechanism of the heart are increased in titin N2B region-deficient mice
E. Lee, J. Peng, M. Radke, M. Gotthardt and H. GranzierArticles
JMOLCELCAR
2010
449--458
18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia
F. Vos, C. Bleeker-Rovers, P. Sturm, P. Krabbe, A. van Dijk, M. Cuijpers, E. Adang, G. Wanten, B. Kullberg and W. OyenArticles
JNM
2010
1234--1240
Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma
A. van de Luijtgaarden, U. Flucke, W. van der Graaf, J. de Rooy, H. Bonenkamp and L. de Geus-OeiArticles
CLINNM
2010
271--272
Hardware failure: a potential pitfall in assessing recurrent Ewing's sarcoma on bone scintigraphy
D. Vriens, A. Arens, J. de Rooy, B. Schreuder, P. Brons and M. GotthardtArticles
CLINNM
2010
430--433
Comparison of two region of interest definition methods for metabolic response evaluation with [textsuperscript1�?�F]FDG-PET
D. Vriens, L. De Geus-Oei, H. Van Laarhoven, H. Der Van Heijden, P. Krabbe, E. Visser and W. OyenArticles
QJNUCMEDMOLIMA
2010
677--688
Benign uterine uptake of FDG: a case report and review of literature
D. Vriens, L. de Geus-Oei, U. Flucke, A. van der Kogel, W. Oyen, M. Vierhout and J. van der MeerArticles
NETHJM
2010
379--380
Methodological considerations in quantification of oncological FDG PET studies
D. Vriens, E. Visser, L. de Geus-Oei and W. OyenArticles
EJNMMI
2010
1408--1425
Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy
M. Melis, J. de Swart, M. de Visser, S. Berndsen, S. Koelewijn, R. Valkema, O. Boerman, E. Krenning and M. de JongArticles
JNM
2010
1962--1968
Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides
M. Melis, E. Vegt, M. Konijnenberg, M. de Visser, M. Bijster, M. Vermeij, E. Krenning, O. Boerman and M. de JongArticles
JNM
2010
973--977
Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases
B. Wiering, E. Adang, J. van der Sijp, R. Roumen, K. de Jong, E. Comans, J. Pruim, H. Dekker, T. Ruers, P. Krabbe and W. OyenArticles
NUCMC
2010
938--944